Hong van Tieu, MD
Co-Head, Laboratory of Infectious Disease Prevention
Associate Member, Lindsley F. Kimball Research Institute
As an Infectious Diseases physician cross-trained in epidemiology at the Columbia University Mailman School of Public Health, Dr. Tieu has a strong research interest in HIV epidemiology (in particular, the intersection of social and sexual networks, drug use, and HIV risk), biomarkers of HIV risk, and HIV biomedical prevention interventions, including HIV vaccine and injectable pre-exposure prophylaxis (PrEP) to prevent HIV infection.
- UM1 AI0569470 NIH/ NIAID PI: Hammer/El-Sadr 2/2007-11/2020 "HIV Vaccine Trials Network (HVTN) Clinical Studies", New York City HIV Vaccine Trials Unit; Sub-contract PI Tieu” Role: NYBC Subcontract PI (Tieu) (2013-) on all Phase 1-3 HIV vaccine research
- UM1 A1068619 NIH/ NIAID PI: Cohen/El-Sadr 1/2015 - 11/2020 “HIV Prevention Trials Network (HPTN)" Role: NYBC Subcontract PI on HPTN 083 (Tieu)
- Merck Investigator Studies Program PI: Tieu 09/2015 - 08/2017 "Mapping Hepatitis C Virus (HCV) Infections among MSM in New York City"
Education and Training
MD, Mount Sinai School of Medicine